JPS61243363A - Highly sensitive assay of crp - Google Patents

Highly sensitive assay of crp

Info

Publication number
JPS61243363A
JPS61243363A JP8437785A JP8437785A JPS61243363A JP S61243363 A JPS61243363 A JP S61243363A JP 8437785 A JP8437785 A JP 8437785A JP 8437785 A JP8437785 A JP 8437785A JP S61243363 A JPS61243363 A JP S61243363A
Authority
JP
Japan
Prior art keywords
antibody
crp
antigen
measured
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP8437785A
Other languages
Japanese (ja)
Inventor
Kazuaki Yoshikawa
吉川 和明
Fujio Shimizu
清水 富士雄
Mitsuru Takada
高田 満
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NITSUSUI SEIYAKU KK
Nissui Pharmacetuical Co Ltd
Original Assignee
NITSUSUI SEIYAKU KK
Nissui Pharmacetuical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NITSUSUI SEIYAKU KK, Nissui Pharmacetuical Co Ltd filed Critical NITSUSUI SEIYAKU KK
Priority to JP8437785A priority Critical patent/JPS61243363A/en
Publication of JPS61243363A publication Critical patent/JPS61243363A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PURPOSE:To obtain a highly sensitive CRP measurement method, by differentiating the kind of animal to be immunized for obtaining a solid-phase antibody and a labelled antibody. CONSTITUTION:An anti-CRP rabbit IgG is used as solid phase antibody while an anti-CRP goat IgG as labelled antibody to react with a sample as measuring antigen (CRP serum) and then, the activity of the labelled substance involving the antigen-antibody reaction is measured to assay CRP. When a 1-step method is applied, a washing (b/f separation) is done after the simultaneous reaction of the solid-phase antibody and the labelled antibody with the measuring antigen (CRP serum sample) and then, the measurement of the activity of the labelled substance involving the antigen-antibody reaction. When a 2-step method is applied, initially, the solid-phase antibody is made to react with the measuring antigen and after a washing, the labelled antibody is added. Following a washing is done again, the activity of the labelled substance is measured.

Description

【発明の詳細な説明】 (産業上の利用分野) 本発明はCRP、即ちC反応性蛋白の定量法に係り、殊
にその高感度定量法に係る。
DETAILED DESCRIPTION OF THE INVENTION (Industrial Application Field) The present invention relates to a method for quantifying CRP, that is, C-reactive protein, and particularly to a highly sensitive method for quantifying CRP.

周知のように、CRPは炎症や組織壊死の結果として血
中に出現する異常蛋白であり、生体に上記のような疾患
が生じた場合に6−24時間で増量して2−5日で最高
レベルに達し、疾患の回復に伴い漸次減量して消失する
と謂う特性を有している。
As is well known, CRP is an abnormal protein that appears in the blood as a result of inflammation and tissue necrosis, and when the above-mentioned diseases occur in the body, the amount increases within 6-24 hours and reaches a peak within 2-5 days. It has the property of reaching a certain level and gradually decreasing and disappearing as the disease recovers.

従って、本発明方法は上記疾患の臨床診断に利用するこ
とができる。
Therefore, the method of the present invention can be used for clinical diagnosis of the above-mentioned diseases.

(従来の技術) 従来のCRP検査法としては毛細管法、ラテックス凝集
法、−元免疫拡散法(SRID法)等のルーチン検査法
や免疫比濁法がある。
(Prior Art) Conventional CRP testing methods include routine testing methods such as capillary tube method, latex agglutination method, and SRID method, and immunoturbidimetry.

ルーチン検査法はCRP値の変動を時間の経過と共に定
量的に把握することが不可能であったり、測定感度、精
度又は操作処理時間に基因して殊に低濃度域におけるC
RP値の変動の把握に難点を有している。
Routine testing methods may not be able to quantitatively understand changes in CRP values over time, or may be difficult to detect due to measurement sensitivity, accuracy, or processing time, especially in low concentration ranges.
It is difficult to understand the fluctuation of RP value.

一方、酵素免疫測定法(EIA)において多用されてい
る所謂サンドイツチ法に関しては固相化抗体と、標識抗
体と、測定抗原とを同時に反応させ、次いで洗浄してb
/f分離(免疫複合体すと。
On the other hand, in the so-called Sanderutsch method, which is frequently used in enzyme-linked immunosorbent assay (EIA), a solid-phase antibody, a labeled antibody, and an antigen to be measured are reacted simultaneously, and then washed.
/f separation (immune complex).

抗原抗体反応に関与しなかったフリーの#Affi抗体
fと抗体能)を行い、その後に抗原抗体反応に関与した
iIA識物質物質性を測定してCRPを定量する1ステ
ップサンドインチ法と、固相化抗体と測定抗原とを先ず
反応させ、次いで洗浄して第1回のb/f分離を行い、
これを次いで標識抗体と反応させた後に第2回のb/f
分離を行い、その後に抗原抗体反応に関与した標識物質
の活性を測定してCRPを定量する2ステップサンドイ
ンチ法とがある。
The one-step sandwich method involves performing free #Affi antibody f that did not participate in the antigen-antibody reaction and antibody activity), and then measuring the iIA identification material that was involved in the antigen-antibody reaction to quantify CRP. The phased antibody and the antigen to be measured are first reacted, and then washed to perform the first b/f separation,
This is then reacted with a labeled antibody, followed by a second b/f
There is a two-step sandwich method in which CRP is quantified by separating and then measuring the activity of a labeling substance involved in the antigen-antibody reaction.

(発明が解決しようとする問題点) 従来の1ステツプ法は、b/f分離操作(洗浄処理)が
1回であり、従って所要時間が短い点において有利では
あるが、測定抗原に対して固相化抗体と標識抗体との競
合反応が生起すると正確なり/f分離が困難となり、そ
の結果として測定感度が低下して測定値が変動する点に
問題があった。
(Problems to be Solved by the Invention) The conventional one-step method is advantageous in that the b/f separation operation (washing treatment) is performed once, and therefore the time required is short; When a competitive reaction occurs between the phased antibody and the labeled antibody, accurate/f separation becomes difficult, resulting in a problem in that the measurement sensitivity decreases and the measured value fluctuates.

一方、2ステツプ法は、1ステツプ法における上記欠陥
を克服するために提案された方法であるが、測定抗原と
の反応を個別に行い、b/f分離操作を2度必要とする
ために工程数が増加し、相当して所要時間が長くなる点
に問題があった。
On the other hand, the two-step method is a method proposed to overcome the above-mentioned deficiencies in the one-step method. There is a problem in that the number increases and the time required increases accordingly.

更に、従来の2ステツプ法による測定感度は比較的高い
が、標識抗体の希釈倍率を高めても充分な測定感度が得
られるようになし、これによって低濃度域のCRP測定
を精確ならしめることが望まれている。
Furthermore, although the measurement sensitivity of the conventional two-step method is relatively high, sufficient measurement sensitivity can be obtained even if the dilution rate of the labeled antibody is increased, thereby making it possible to accurately measure CRP in the low concentration range. desired.

(発明の目的並びに問題点を解決するための手段及び作
用) 従って、本発明の目的は、従来よりも更に高感度なCR
P測定法を提供することにある。
(Objective of the invention and means and effects for solving the problems) Therefore, an object of the present invention is to provide a CR with even higher sensitivity than before.
The purpose of this invention is to provide a method for measuring P.

本発明は、同相化抗体と標識抗体とを得るために免疫さ
れる動物種を異ならしめることを基本とするものであり
、本発明方法によれば固相化抗体として抗CRPウサギ
IgGを且つ標識抗体として抗CRPヤギIgGを用い
て測定抗原である試料(CRP血清)と反応させ、次い
で抗原抗体反応に関与した標識物質の活性を測定してC
RPを定量することにより、上記目的を達成することが
できる。
The present invention is based on different animal species to be immunized in order to obtain a homologous antibody and a labeled antibody, and according to the method of the present invention, anti-CRP rabbit IgG is used as the immobilized antibody and labeled Anti-CRP goat IgG is used as an antibody to react with the sample (CRP serum) that is the antigen to be measured, and then the activity of the labeling substance involved in the antigen-antibody reaction is measured.
The above objective can be achieved by quantifying RP.

本発明方法は1ステツプ法にも2ステツプ法にも適用す
ることができる。1ステツプ法に適用する場合には固相
化抗体と、標識抗体と、測定抗原(CRP血清試料)と
を同時に反応させた後に洗浄(b/f分離)を行い、そ
の後に抗原抗体反応に関与した標識物質の活性測定が行
われる。この場合に測定感度が若干低下する場合がある
が、これは固相化抗体と測定抗原との反応と、測定抗原
と標識抗体との反応に若干の時間的ずれを与えることに
より、即ち先ず同相化抗体と測定抗原との反応を行わせ
、その後に標識抗体を添加して更に反応を行わせること
により防止することができる。
The method of the invention can be applied to both one-step and two-step methods. When applied to the one-step method, the immobilized antibody, labeled antibody, and antigen to be measured (CRP serum sample) are reacted at the same time, then washed (b/f separation), and then involved in the antigen-antibody reaction. The activity of the labeled substance is measured. In this case, the measurement sensitivity may decrease slightly, but this can be done by providing a slight time lag between the reaction between the immobilized antibody and the antigen to be measured and the reaction between the antigen to be measured and the labeled antibody. This can be prevented by causing a reaction between the labeled antibody and the antigen to be measured, and then adding a labeled antibody and causing a further reaction.

2ステツプ法に適用する場合には、固相化抗体と測定抗
原とが先ず反応せしめられ、次いで洗浄の行われた後に
、標識抗体が添加され更めて反応が行われ1次いで再び
洗浄され、その後に1ステツプ法と同様にして抗原抗体
反応に関与した標識物質の活性測定が行われる。
When applied to a two-step method, the immobilized antibody and the antigen to be measured are first reacted, then washed, a labeled antibody is added, another reaction is carried out, and then washed again. Thereafter, the activity of the labeling substance involved in the antigen-antibody reaction is measured in the same manner as in the one-step method.

抗体の標識に用いられる物質としては慣用のもの、例え
ばアルカリホスファターゼ等の酵素、フルオレセインイ
ソシアネート等の蛍光物質、色素、放射性物質等から選
ばれた任意のものを用いることができるが、取扱い性、
入手容易性等の観点から酵素例えばアルカリホスファタ
ーゼを用いるのが好都合である。標識を付す方法として
は自体周知の方法を採用することができる。
As the substance used for labeling the antibody, any commonly used substance can be used, such as enzymes such as alkaline phosphatase, fluorescent substances such as fluorescein isocyanate, dyes, radioactive substances, etc. However, ease of handling,
From the viewpoint of availability, it is convenient to use an enzyme such as alkaline phosphatase. As a method for attaching a label, a method known per se can be adopted.

抗原抗体反応に関与した標識物質の活性測定も自体公知
の方法により実施することができる。例えば標識物質と
してアルカリホスファターゼを用いた場合には、その測
定用基質液を添加して反応させ、次いで発色液を添加し
て酵素反応を停止させると共に発色させ、これを例えば
測定機器により測光(吸光度測定)して行うことができ
る。測定抗原のCRP定量はこの吸光度値を標準検量線
に照合することにより行うことができる。
The activity of the labeling substance involved in the antigen-antibody reaction can also be measured by methods known per se. For example, when alkaline phosphatase is used as a labeling substance, a substrate solution for its measurement is added and reacted, a coloring solution is added to stop the enzymatic reaction and color is developed, and this is measured photometrically (absorbance) using a measuring device. measurement). CRP quantification of the antigen to be measured can be performed by comparing this absorbance value with a standard calibration curve.

(発明の効果) 抗原抗体反応を利用する5所謂サンドイツチ法によるC
 R,Pの定量において、本発明によれば、特定の動物
種を免疫させて得た抗体即ち固相化抗体として抗CRP
ウサギIgGを、又標識抗体として抗CRPヤギIgG
を選択することによ℃その測定感度を向上させることが
可能となる。このことは測定感度を一定とすれば、標識
抗体の希釈倍率を高め得ることを意味しており、従って
希釈倍率を高く設定することにより、標識抗体による非
特異吸着の影響を著しく低下させることができるので、
低濃度域における測定精度の向上をも達成することがで
きる。
(Effects of the invention) C by the so-called Sanderutsch method using antigen-antibody reaction
According to the present invention, in the determination of R and P, anti-CRP is used as an antibody obtained by immunizing a specific animal species, that is, as an immobilized antibody.
Rabbit IgG and anti-CRP goat IgG as a labeled antibody
By selecting ℃, it is possible to improve the measurement sensitivity. This means that if the measurement sensitivity is kept constant, the dilution rate of the labeled antibody can be increased. Therefore, by setting a high dilution rate, the influence of nonspecific adsorption due to the labeled antibody can be significantly reduced. Because you can
It is also possible to improve measurement accuracy in the low concentration range.

(実施例) 次に、本発明方法の実施の一例について説明する。明す
る。
(Example) Next, an example of implementing the method of the present invention will be described. I will clarify.

A)抗体の調製 血清中のヒトCRPをウサギ及びヤギに静注して免疫さ
せ、採血して抗ヒトCRP血清を得て、これを硫安塩析
、イオン交換してIgG分画を調製した。
A) Preparation of antibodies Rabbits and goats were immunized by intravenously injecting human CRP in serum, blood was collected to obtain anti-human CRP serum, which was subjected to ammonium sulfate salting out and ion exchange to prepare an IgG fraction.

B)固相化抗体の調製 上記A項による抗ヒトCRP抗体(IgGフラクション
)を0.05M炭酸緩衝液(pH9,6)+:希釈して
50μg/mlの抗体溶液となし、これをNunc社製
のマイクロタイタープレートの各ウェルに200μm宛
分注した。このウェルを4−10℃で24時間放置した
後にウェル内容物を蒸留水で洗浄した。次いで、各ウェ
ル内に1%アルブミン含有燐酸緩衝食塩水(pH7,2
)を200μm宛分注し、4−10℃で更に24時間放
置して固相化抗体とした。
B) Preparation of immobilized antibody The anti-human CRP antibody (IgG fraction) obtained in Section A above was diluted with 0.05 M carbonate buffer (pH 9,6) +: to make an antibody solution of 50 μg/ml, which was prepared by Nunc Co., Ltd. A 200 μm aliquot was dispensed into each well of a microtiter plate made by Manufacturer Co., Ltd. After the wells were left at 4-10°C for 24 hours, the contents of the wells were washed with distilled water. Next, phosphate buffered saline (pH 7, 2) containing 1% albumin was added to each well.
) was dispensed into 200 μm portions and left at 4-10° C. for an additional 24 hours to obtain immobilized antibodies.

尚、この固相化抗体は使用に先立ち蒸留水で洗浄される
Note that this immobilized antibody is washed with distilled water before use.

C)標識抗体の調製 アルカリホスファターゼ(仔牛小腸起原、べ一リンガ社
製) 3mg ttl mM塩化マグネシウム含有0.
1M N、N−ビス(2−ヒドロキシエチル)−グリシ
ン緩衝液(pH8,5) 1 mlに添加して溶解させ
、次いで過沃素酸カリウム20 mgを添加し、37℃
で2時間放置した。その後に80Orpmで5分間遠心
して不溶物を除去し、上清を1 mM塩化マグネシウム
含有0.1M炭酸緩衝液(pH9,5)で−晩透析した
。次いで、上記A項による抗ヒトCRP抗体(IgGフ
ラクション) 1.5 mgを添加し、4−10℃で1
4日間放置し、1%牛アルブミン含有燐酸緩衝食塩水で
50倍に希釈した後に凍結保存した。
C) Preparation of labeled antibody Alkaline phosphatase (derived from calf small intestine, manufactured by Beringa) 3 mg ttl containing 0.0 mg ttl mM magnesium chloride.
Add and dissolve in 1 ml of 1M N,N-bis(2-hydroxyethyl)-glycine buffer (pH 8,5), then add 20 mg of potassium periodate, and heat at 37°C.
I left it for 2 hours. Thereafter, insoluble materials were removed by centrifugation at 80 rpm for 5 minutes, and the supernatant was dialyzed overnight against 0.1 M carbonate buffer (pH 9.5) containing 1 mM magnesium chloride. Next, 1.5 mg of the anti-human CRP antibody (IgG fraction) according to section A above was added, and the mixture was incubated at 4-10°C for 1.5 mg.
The mixture was left for 4 days, diluted 50 times with phosphate buffered saline containing 1% bovine albumin, and then stored frozen.

尚、使用時には、0.1%牛アルブミン含有燐酸緩衝食
塩水で所要希釈率のものとなす。
In addition, at the time of use, the required dilution rate is made with phosphate buffered saline containing 0.1% bovine albumin.

D)測定法 a)1ステツプ法 上記り項による標識抗体の希釈液200μmを抗体固相
化マイクロタイタープレートの各ウェルに分注し、試料
(CRP血清)20μlを添加し、室温で2時間反応さ
せた後に内容物を蒸留水で洗浄する。次いでアルカリホ
スファターゼ活性測定用基質液(45mMフェニル燐酸
2ナトリウム及び2mM4−アミノアンチピリン含有0
.025 M炭酸緩衝液、PH10,2)を200μm
添加し、室温で20分間反応させる。
D) Measurement method a) One-step method Dispense 200 μm of the diluted solution of the labeled antibody according to the above section into each well of an antibody-immobilized microtiter plate, add 20 μl of sample (CRP serum), and react at room temperature for 2 hours. After that, wash the contents with distilled water. Next, a substrate solution for measuring alkaline phosphatase activity (containing 45 mM disodium phenylphosphate and 2 mM 4-aminoantipyrine) was added.
.. 025 M carbonate buffer, PH10,2) at 200 μm
Add and react for 20 minutes at room temperature.

その後に1発色液(0,8%過沃素酸ナトリウム)10
0μmを添加して酵素反応を停止させると共に発色を生
じさせた。
After that, 1 color developer (0.8% sodium periodate) 10
0 μm was added to stop the enzyme reaction and cause color development.

次いで、ELIsAアナライザ(ETY−96)により
吸光度測定を行う。
Next, absorbance measurement is performed using an ELIsA analyzer (ETY-96).

b)1ステツプ改良法 0.1%牛アルブミン含有燐酸緩衝食塩水100μmを
抗体固相化マイクロタイタープレートに分注し、試料2
0μmを添加し、室温で1時間反応させる。
b) 1-step improved method Dispense 100 μm of phosphate buffered saline containing 0.1% bovine albumin into an antibody-immobilized microtiter plate, and prepare sample 2.
Add 0 μm and react for 1 hour at room temperature.

次いで、上記0項による標識抗体の希釈液100μmを
添加し、室温で1時間反応させた後に蒸留水で洗浄する
。その後に、上記a項におけると同様にして、抗原抗体
反応に関与したアルカリホスファターゼの活性測定を行
う。
Next, 100 μm of a diluted solution of the labeled antibody according to item 0 above is added, and after reacting for 1 hour at room temperature, the plate is washed with distilled water. Thereafter, the activity of alkaline phosphatase involved in the antigen-antibody reaction is measured in the same manner as in section a above.

c)2ステツプ法 0.1%牛アルブミン含有燐酸緩衝食塩水100μlを
抗ヒトCRP抗体が固相化されたマイクロタイタープレ
ートの各ウェルに分注し、試料20μmを添加し、室温
で1時間反応させる。次いで、蒸留水で洗浄し、0.1
%牛アルブミン含有燐酸緩衝食塩水により希釈した上記
0項による標識抗体の希釈液200μlを添加し、室温
で1時間反応させる。その後に蒸留水で洗浄し、次いで
上記a項におけると同様にして、抗原抗体反応に関与し
たアルカリホスファターゼの活性測定が行われる。
c) 2-step method Dispense 100 μl of phosphate buffered saline containing 0.1% bovine albumin into each well of a microtiter plate immobilized with anti-human CRP antibody, add 20 μm of sample, and react for 1 hour at room temperature. let Then, it was washed with distilled water and 0.1
Add 200 μl of a diluted solution of the labeled antibody according to item 0 above diluted with phosphate buffered saline containing % bovine albumin, and react at room temperature for 1 hour. Thereafter, it is washed with distilled water, and then the activity of alkaline phosphatase involved in the antigen-antibody reaction is measured in the same manner as in section a above.

E)結果 各種CRP濃度の試料を調製し、上記F測定法」の項に
記載の操作手順に従い且つ固相化抗体としてウサギIg
G及びヤギIgGを、又標識抗体としてヤギIgG及び
ウサギIgGを用いて試験を行い、CRP濃度と吸光度
(500nm)との関係を調べた処第1−3図に示され
る結果が得られた。
E) Results Samples with various CRP concentrations were prepared, and rabbit Ig was used as the immobilized antibody according to the operating procedure described in the section ``F measurement method'' above.
Tests were conducted using G and goat IgG, and goat IgG and rabbit IgG as labeled antibodies, and the relationship between CRP concentration and absorbance (500 nm) was investigated, and the results shown in Figures 1-3 were obtained.

第1−3図は1ステップ法、1ステツプ改良法及び2ス
テツプ法を実施した場合にプロットして得られたグラフ
をそれぞれ示しており、これから本発明による方法は測
定感度が極めて良好であること、殊に1ステツプ法でも
充分であること並びに低濃度域での測定に有効であるこ
とが判る。
Figures 1-3 show graphs obtained by plotting the one-step method, one-step improved method, and two-step method, respectively, and it can be seen that the method according to the present invention has extremely good measurement sensitivity. It has been found that the one-step method is particularly sufficient and effective for measurements in the low concentration range.

尚、これら図中においてR−G、 R−R,G−G及び
G−Rはそれぞれ下記表の通りの抗体組合せを示すもの
である。
In these figures, RG, RR, GG, and GR each represent the antibody combination as shown in the table below.

【図面の簡単な説明】[Brief explanation of the drawing]

図面は本発明方法を実施する場合のCRP濃度と吸光度
との関係を示すグラフであって、第1図は1ステツプ法
を適用した場合、第2図は1ステツプ改良法を適用した
場合、第3図は2ステツプ法を適用した場合をそれぞれ
示すものである。
The drawings are graphs showing the relationship between CRP concentration and absorbance when carrying out the method of the present invention. Figure 3 shows the case where the two-step method is applied.

Claims (4)

【特許請求の範囲】[Claims] (1)固相化抗体として抗CRPウサギIgGを且つ標
識抗体として抗CRPヤギIgGを用いて測定抗原であ
るCRP試料と反応させ、次いで抗原抗体反応に関与し
た標識物質の活性を測定してCRPを定量することを特
徴とする、CRPの高感度定量法。
(1) Using anti-CRP rabbit IgG as the immobilized antibody and anti-CRP goat IgG as the labeled antibody, react with the CRP sample that is the antigen to be measured, and then measure the activity of the labeled substance involved in the antigen-antibody reaction. A highly sensitive method for quantifying CRP, which is characterized by quantifying CRP.
(2)固相化抗体と、標識抗体と、測定抗原とを同時に
反応させ、洗浄し、その後に標識物質の活性測定をする
ことを特徴とする、特許請求の範囲第1項に記載の高感
度定量法。
(2) The method according to claim 1, characterized in that the immobilized antibody, the labeled antibody, and the antigen to be measured are simultaneously reacted, washed, and then the activity of the labeled substance is measured. Sensitivity quantification method.
(3)固相化抗体と測定抗原とを先ず反応させ、次いで
標識抗体を添加して更に反応を行わせた後に洗浄し、そ
の後に標識物質の活性測定をすることを特徴とする、特
許請求の範囲第1項に記載の高感度定量法。
(3) A patent claim characterized in that the immobilized antibody and the antigen to be measured are first reacted, then a labeled antibody is added and the reaction is further carried out, followed by washing, and then the activity of the labeled substance is measured. The high-sensitivity quantitative method according to item 1.
(4)固相化抗体と標識抗体とを反応させた後に洗浄し
、これを次いで標識抗体と反応させた後に再度洗浄し、
その後に標識物質の活性測定をすることを特徴とする、
特許請求の範囲第1項に記載の高感度定量法。
(4) Washing after reacting the immobilized antibody with the labeled antibody, and then washing it again after reacting with the labeled antibody,
characterized in that the activity of the labeled substance is then measured;
A highly sensitive quantitative method according to claim 1.
JP8437785A 1985-04-22 1985-04-22 Highly sensitive assay of crp Pending JPS61243363A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP8437785A JPS61243363A (en) 1985-04-22 1985-04-22 Highly sensitive assay of crp

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8437785A JPS61243363A (en) 1985-04-22 1985-04-22 Highly sensitive assay of crp

Publications (1)

Publication Number Publication Date
JPS61243363A true JPS61243363A (en) 1986-10-29

Family

ID=13828847

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8437785A Pending JPS61243363A (en) 1985-04-22 1985-04-22 Highly sensitive assay of crp

Country Status (1)

Country Link
JP (1) JPS61243363A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6415656A (en) * 1987-07-09 1989-01-19 Nissui Seiyaku Co Method for quantifying c reactive protein
JPS6488155A (en) * 1987-06-22 1989-04-03 Ruijiana State Univ Found The Immunological inspection for detecting antibody against antigen
WO2010013789A1 (en) * 2008-08-01 2010-02-04 国立大学法人岡山大学 Protein production method, fusion protein, and antiserum
JP2010520461A (en) * 2007-03-01 2010-06-10 アボット・ラボラトリーズ Immunoassay showing reduced prozone phenomenon
EP2336158A1 (en) * 2009-12-21 2011-06-22 Fujifilm Corporation Dry analytical element for measurement of canine CRP

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5386015A (en) * 1976-12-29 1978-07-29 Wako Pure Chem Ind Ltd Novel immunoassay of crp
JPS5716355A (en) * 1980-04-25 1982-01-27 Hoffmann La Roche Immunological method
JPS58211659A (en) * 1982-06-03 1983-12-09 Nitsusui Seiyaku Kk Handy and quick assay of serum crp by immunological nephelometry
JPS59163565A (en) * 1983-03-08 1984-09-14 Toray Ind Inc Microdetermination method of high molecular antigen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5386015A (en) * 1976-12-29 1978-07-29 Wako Pure Chem Ind Ltd Novel immunoassay of crp
JPS5716355A (en) * 1980-04-25 1982-01-27 Hoffmann La Roche Immunological method
JPS58211659A (en) * 1982-06-03 1983-12-09 Nitsusui Seiyaku Kk Handy and quick assay of serum crp by immunological nephelometry
JPS59163565A (en) * 1983-03-08 1984-09-14 Toray Ind Inc Microdetermination method of high molecular antigen

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6488155A (en) * 1987-06-22 1989-04-03 Ruijiana State Univ Found The Immunological inspection for detecting antibody against antigen
JPS6415656A (en) * 1987-07-09 1989-01-19 Nissui Seiyaku Co Method for quantifying c reactive protein
JP2010520461A (en) * 2007-03-01 2010-06-10 アボット・ラボラトリーズ Immunoassay showing reduced prozone phenomenon
WO2010013789A1 (en) * 2008-08-01 2010-02-04 国立大学法人岡山大学 Protein production method, fusion protein, and antiserum
JP4604231B2 (en) * 2008-08-01 2011-01-05 国立大学法人 岡山大学 Protein production method, fusion protein and antiserum
JPWO2010013789A1 (en) * 2008-08-01 2012-01-12 国立大学法人 岡山大学 Protein production method, fusion protein and antiserum
US8865428B2 (en) 2008-08-01 2014-10-21 National University Corporation Okayama University Protein production method, fusion protein, and antiserum
EP2336158A1 (en) * 2009-12-21 2011-06-22 Fujifilm Corporation Dry analytical element for measurement of canine CRP

Similar Documents

Publication Publication Date Title
US20180259511A1 (en) Multiple hybrid immunoassay
RU2058032C1 (en) Method for detecting substances having at least one antigen determinant site
KR100237239B1 (en) Ultrasensitive process for assaying cardiac troponine 1
JPH09508707A (en) Competitive binding assay with improved linearity
JPH07325083A (en) Method for measuring ratio of specific sugar chain of glycoprotein
JPS61243363A (en) Highly sensitive assay of crp
US20100081149A1 (en) Novel oxidized ldl complex and method for detection thereof
JPS6223823B2 (en)
Hiroyuki et al. An enzyme immunoassay system for measurement of serum insulin
JPH03170058A (en) Reagent complex for immunoassay
US5436132A (en) Quantitative determination of tenascin as glioma marker
EP1218749B1 (en) Detection of prostate cancer measuring psa/igf-1 ratio
JPH07309895A (en) New protein, method for detecting the same and diagnostic
KR940008091B1 (en) Method for the immunological determination of ligands
JP2534067B2 (en) Quantitative method for C-reactive protein
WO2023068249A1 (en) Measuring reagent for cross-linked n-telopeptide of type i collagen, preparation method thereof, and immunoassay method using same
Ludlam et al. Plasminogen assay by a haemagglutination inhibition technique
JP3175822B2 (en) Hapten immunoassay
JPH0466871A (en) High sensitive immunoassay
Blanchard et al. A solid-phase fluoroimmunoassay for human IgE
JPH1164334A (en) Measuring method of urine trypsin inhibitor
JPH04233462A (en) Immunological quantitative analysis
JP3768165B2 (en) Method and kit for measuring anti-carpastatin antibody
JP2521074B2 (en) How to regulate the immune response
RU2180117C1 (en) Method of estimation of sensitization to chemical compounds